P

Inventor

AFAR DANIEL E H

US58 patents
⚠️ This page may combine multiple inventors who share the name “AFAR DANIEL E H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AGENSYS INC

47 patents
US7507541B2Mar 24, 2009

36P6D5: secreted tumor antigen

AGENSYS INC89 citations98
US7166714B2Jan 23, 2007

Serpentine transmembrane antigens expressed in human cancers and uses thereof

AGENSYS INC35 citations96
US7641905B2Jan 5, 2010

Methods of inducing an immune response

AGENSYS INC25 citations93
US7628989B2Dec 8, 2009

Methods of inducing an immune response

AGENSYS INC23 citations93
US6602501B1Aug 5, 2003

C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof

AGENSYS INC13 citations93
US7947459B2May 24, 2011

Serpentine transmembrane antigens expressed in human cancers and uses thereof

AGENSYS INC19 citations92
US7510840B1Mar 31, 2009

Method of inhibiting growth or survival of a cell by providing an anti-108P5H8 antibody

AGENSYS INC16 citations92
US7459539B2Dec 2, 2008

Antibody that binds zinc transporter protein 108P5H8

AGENSYS INC16 citations92
US7455991B2Nov 25, 2008

Serpentine transmembrane antigens expressed in human cancers and uses thereof

AGENSYS INC14 citations92
US7223542B2May 29, 2007

36P6D5: secreted tumor antigen

AGENSYS INC13 citations92
US7037667B1May 2, 2006

Tumor antigen useful in diagnosis and therapy of prostate and colon cancer

AGENSYS INC41 citations92
US6893818B1May 17, 2005

Gene upregulated in cancers of the prostate

AGENSYS INC19 citations92
US7795391B2Sep 14, 2010

Protein showing enhanced expression in cancer cells

AGENSYS INC8 citations84
US6566078B1May 20, 2003

36P6D5: secreted tumor antigen

AGENSYS INC12 citations82
US7227008B2Jun 5, 2007

13-transmembrane protein expressed in prostate cancer

AGENSYS INC5 citations74
US6924358B2Aug 2, 2005

121P1F1: a tissue specific protein highly expressed in various cancers

AGENSYS INC5 citations74
US6835822B1Dec 28, 2004

Diagnosis and therapy of cancer using SGP28-related molecules

AGENSYS INC7 citations74
US7928212B2Apr 19, 2011

Gene upregulated in cancers of the prostate

AGENSYS INC1 citations63
US7771968B2Aug 10, 2010

Gene upregulated in cancers of the prostate

AGENSYS INC2 citations63
US7736654B2Jun 15, 2010

Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers

AGENSYS INC1 citations63
US7569356B2Aug 4, 2009

Diagnosis and therapy of cancer using SGP28-related molecules

AGENSYS INC1 citations63
US7488479B2Feb 10, 2009

Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer

AGENSYS INC1 citations63
US7351583B2Apr 1, 2008

Antibodies to G protein-coupled receptor

AGENSYS INC1 citations63
US7271240B2Sep 18, 2007

125P5C8: a tissue specific protein highly expressed in various cancers

AGENSYS INC2 citations63
US7153940B2Dec 26, 2006

C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof

AGENSYS INC1 citations63
US7087718B2Aug 8, 2006

C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof

AGENSYS INC1 citations63
US6838258B2Jan 4, 2005

G protein-coupled receptor up-regulated in prostate cancer and uses thereof

AGENSYS INC1 citations63
US6790631B1Sep 14, 2004

G protein-coupled receptor up-regulated in prostate cancer and uses thereof

AGENSYS INC1 citations63
US7601825B2Oct 13, 2009

Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer

AGENSYS INC3 citations61
US6863892B2Mar 8, 2005

Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers

AGENSYS INC5 citations60
US8039000B2Oct 18, 2011

Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer

AGENSYS INC0 citations52
US8039603B2Oct 18, 2011

Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer

AGENSYS INC0 citations52
US8022174B2Sep 20, 2011

C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof

AGENSYS INC0 citations52
US7968283B2Jun 28, 2011

Gene expressed in prostate cancer

AGENSYS INC0 citations52
US7951375B2May 31, 2011

Methods of inducing an immune response

AGENSYS INC0 citations52
US7928196B2Apr 19, 2011

Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer

AGENSYS INC0 citations52
US7897740B2Mar 1, 2011

Secreted protein called 36P6D5 characteristic of tumors

AGENSYS INC0 citations52
US7892548B2Feb 22, 2011

121P1F1: a tissue specific protein highly expressed in various cancers

AGENSYS INC0 citations52
US7858760B2Dec 28, 2010

Antibodies to protein expressed in prostate cancer

AGENSYS INC0 citations52
US7834156B2Nov 16, 2010

125P5C8: tissue specific protein highly expressed in various cancers

AGENSYS INC0 citations52
US7759474B2Jul 20, 2010

Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer

AGENSYS INC0 citations52
US7598045B2Oct 6, 2009

C-type LECTIN transmembrane antigen expressed in human prostate cancer and uses thereof

AGENSYS INC0 citations52
US7309585B2Dec 18, 2007

121P1F1: a tissue specific protein highly expressed in various cancers

AGENSYS INC0 citations52
US7208280B2Apr 24, 2007

Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer

AGENSYS INC1 citations52
US7148337B2Dec 12, 2006

C-type LECTIN transmembrane antigen expressed in human prostate cancer and uses thereof

AGENSYS INC0 citations52
US8013126B2Sep 6, 2011

84P2A9: a prostate and testis specific protein highly expressed in prostate cancer

AGENSYS INC0 citations51
US7981624B2Jul 19, 2011

Methods to detect tumors using 20P1F12/TMPRSS2 expression

AGENSYS INC0 citations51

ABBVIE BIOTHERAPEUTICS INC

1 patent

HUBERT RENE S

1 patent

CEDARS SINAI MEDICAL CENTER

1 patent

Showing the top 50 of 58 patents by PatentIndex Score.